Global Recombinant Factor VIII Market Growth 2022-2028
- LP 4871186
- 96 Pages
- February 2022
- Pharmaceuticals
The United States Recombinant Factor VIII market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Recombinant Factor VIII market, reaching US$ million by the year 2028. As for the Europe Recombinant Factor VIII landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Recombinant Factor VIII players cover Takeda, Bayer, CSL, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Factor VIII market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
200IU
250IU
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Takeda
Bayer
CSL
Pfizer
Biogen
Octapharma
NovoNordisk
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Recombinant Factor VIII Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Recombinant Factor VIII by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Recombinant Factor VIII by Country/Region, 2017, 2022 & 2028
2.2 Recombinant Factor VIII Segment by Type
2.2.1 200IU
2.2.2 250IU
2.3 Recombinant Factor VIII Sales by Type
2.3.1 Global Recombinant Factor VIII Sales Market Share by Type (2017-2022)
2.3.2 Global Recombinant Factor VIII Revenue and Market Share by Type (2017-2022)
2.3.3 Global Recombinant Factor VIII Sale Price by Type (2017-2022)
2.4 Recombinant Factor VIII Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Recombinant Factor VIII Sales by Application
2.5.1 Global Recombinant Factor VIII Sale Market Share by Application (2017-2022)
2.5.2 Global Recombinant Factor VIII Revenue and Market Share by Application (2017-2022)
2.5.3 Global Recombinant Factor VIII Sale Price by Application (2017-2022)
3 Global Recombinant Factor VIII by Company
3.1 Global Recombinant Factor VIII Breakdown Data by Company
3.1.1 Global Recombinant Factor VIII Annual Sales by Company (2020-2022)
3.1.2 Global Recombinant Factor VIII Sales Market Share by Company (2020-2022)
3.2 Global Recombinant Factor VIII Annual Revenue by Company (2020-2022)
3.2.1 Global Recombinant Factor VIII Revenue by Company (2020-2022)
3.2.2 Global Recombinant Factor VIII Revenue Market Share by Company (2020-2022)
3.3 Global Recombinant Factor VIII Sale Price by Company
3.4 Key Manufacturers Recombinant Factor VIII Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Factor VIII Product Location Distribution
3.4.2 Players Recombinant Factor VIII Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Recombinant Factor VIII by Geographic Region
4.1 World Historic Recombinant Factor VIII Market Size by Geographic Region (2017-2022)
4.1.1 Global Recombinant Factor VIII Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Recombinant Factor VIII Annual Revenue by Geographic Region
4.2 World Historic Recombinant Factor VIII Market Size by Country/Region (2017-2022)
4.2.1 Global Recombinant Factor VIII Annual Sales by Country/Region (2017-2022)
4.2.2 Global Recombinant Factor VIII Annual Revenue by Country/Region
4.3 Americas Recombinant Factor VIII Sales Growth
4.4 APAC Recombinant Factor VIII Sales Growth
4.5 Europe Recombinant Factor VIII Sales Growth
4.6 Middle East & Africa Recombinant Factor VIII Sales Growth
5 Americas
5.1 Americas Recombinant Factor VIII Sales by Country
5.1.1 Americas Recombinant Factor VIII Sales by Country (2017-2022)
5.1.2 Americas Recombinant Factor VIII Revenue by Country (2017-2022)
5.2 Americas Recombinant Factor VIII Sales by Type
5.3 Americas Recombinant Factor VIII Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Factor VIII Sales by Region
6.1.1 APAC Recombinant Factor VIII Sales by Region (2017-2022)
6.1.2 APAC Recombinant Factor VIII Revenue by Region (2017-2022)
6.2 APAC Recombinant Factor VIII Sales by Type
6.3 APAC Recombinant Factor VIII Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Recombinant Factor VIII by Country
7.1.1 Europe Recombinant Factor VIII Sales by Country (2017-2022)
7.1.2 Europe Recombinant Factor VIII Revenue by Country (2017-2022)
7.2 Europe Recombinant Factor VIII Sales by Type
7.3 Europe Recombinant Factor VIII Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Recombinant Factor VIII by Country
8.1.1 Middle East & Africa Recombinant Factor VIII Sales by Country (2017-2022)
8.1.2 Middle East & Africa Recombinant Factor VIII Revenue by Country (2017-2022)
8.2 Middle East & Africa Recombinant Factor VIII Sales by Type
8.3 Middle East & Africa Recombinant Factor VIII Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Factor VIII
10.3 Manufacturing Process Analysis of Recombinant Factor VIII
10.4 Industry Chain Structure of Recombinant Factor VIII
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Factor VIII Distributors
11.3 Recombinant Factor VIII Customer
12 World Forecast Review for Recombinant Factor VIII by Geographic Region
12.1 Global Recombinant Factor VIII Market Size Forecast by Region
12.1.1 Global Recombinant Factor VIII Forecast by Region (2023-2028)
12.1.2 Global Recombinant Factor VIII Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Recombinant Factor VIII Forecast by Type
12.7 Global Recombinant Factor VIII Forecast by Application
13 Key Players Analysis
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Recombinant Factor VIII Product Offered
13.1.3 Takeda Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Recombinant Factor VIII Product Offered
13.2.3 Bayer Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 CSL
13.3.1 CSL Company Information
13.3.2 CSL Recombinant Factor VIII Product Offered
13.3.3 CSL Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 CSL Main Business Overview
13.3.5 CSL Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Recombinant Factor VIII Product Offered
13.4.3 Pfizer Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Biogen
13.5.1 Biogen Company Information
13.5.2 Biogen Recombinant Factor VIII Product Offered
13.5.3 Biogen Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Biogen Main Business Overview
13.5.5 Biogen Latest Developments
13.6 Octapharma
13.6.1 Octapharma Company Information
13.6.2 Octapharma Recombinant Factor VIII Product Offered
13.6.3 Octapharma Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Octapharma Main Business Overview
13.6.5 Octapharma Latest Developments
13.7 NovoNordisk
13.7.1 NovoNordisk Company Information
13.7.2 NovoNordisk Recombinant Factor VIII Product Offered
13.7.3 NovoNordisk Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 NovoNordisk Main Business Overview
13.7.5 NovoNordisk Latest Developments
14 Research Findings and Conclusion
Table 1. Recombinant Factor VIII Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Recombinant Factor VIII Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 200IU
Table 4. Major Players of 250IU
Table 5. Global Recombinant Factor VIII Sales by Type (2017-2022) & (K Units)
Table 6. Global Recombinant Factor VIII Sales Market Share by Type (2017-2022)
Table 7. Global Recombinant Factor VIII Revenue by Type (2017-2022) & ($ million)
Table 8. Global Recombinant Factor VIII Revenue Market Share by Type (2017-2022)
Table 9. Global Recombinant Factor VIII Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Recombinant Factor VIII Sales by Application (2017-2022) & (K Units)
Table 11. Global Recombinant Factor VIII Sales Market Share by Application (2017-2022)
Table 12. Global Recombinant Factor VIII Revenue by Application (2017-2022)
Table 13. Global Recombinant Factor VIII Revenue Market Share by Application (2017-2022)
Table 14. Global Recombinant Factor VIII Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Recombinant Factor VIII Sales by Company (2020-2022) & (K Units)
Table 16. Global Recombinant Factor VIII Sales Market Share by Company (2020-2022)
Table 17. Global Recombinant Factor VIII Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Recombinant Factor VIII Revenue Market Share by Company (2020-2022)
Table 19. Global Recombinant Factor VIII Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Recombinant Factor VIII Producing Area Distribution and Sales Area
Table 21. Players Recombinant Factor VIII Products Offered
Table 22. Recombinant Factor VIII Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Recombinant Factor VIII Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Recombinant Factor VIII Sales Market Share Geographic Region (2017-2022)
Table 27. Global Recombinant Factor VIII Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Recombinant Factor VIII Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Recombinant Factor VIII Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Recombinant Factor VIII Sales Market Share by Country/Region (2017-2022)
Table 31. Global Recombinant Factor VIII Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Recombinant Factor VIII Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Recombinant Factor VIII Sales by Country (2017-2022) & (K Units)
Table 34. Americas Recombinant Factor VIII Sales Market Share by Country (2017-2022)
Table 35. Americas Recombinant Factor VIII Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Recombinant Factor VIII Revenue Market Share by Country (2017-2022)
Table 37. Americas Recombinant Factor VIII Sales by Type (2017-2022) & (K Units)
Table 38. Americas Recombinant Factor VIII Sales Market Share by Type (2017-2022)
Table 39. Americas Recombinant Factor VIII Sales by Application (2017-2022) & (K Units)
Table 40. Americas Recombinant Factor VIII Sales Market Share by Application (2017-2022)
Table 41. APAC Recombinant Factor VIII Sales by Region (2017-2022) & (K Units)
Table 42. APAC Recombinant Factor VIII Sales Market Share by Region (2017-2022)
Table 43. APAC Recombinant Factor VIII Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Recombinant Factor VIII Revenue Market Share by Region (2017-2022)
Table 45. APAC Recombinant Factor VIII Sales by Type (2017-2022) & (K Units)
Table 46. APAC Recombinant Factor VIII Sales Market Share by Type (2017-2022)
Table 47. APAC Recombinant Factor VIII Sales by Application (2017-2022) & (K Units)
Table 48. APAC Recombinant Factor VIII Sales Market Share by Application (2017-2022)
Table 49. Europe Recombinant Factor VIII Sales by Country (2017-2022) & (K Units)
Table 50. Europe Recombinant Factor VIII Sales Market Share by Country (2017-2022)
Table 51. Europe Recombinant Factor VIII Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Recombinant Factor VIII Revenue Market Share by Country (2017-2022)
Table 53. Europe Recombinant Factor VIII Sales by Type (2017-2022) & (K Units)
Table 54. Europe Recombinant Factor VIII Sales Market Share by Type (2017-2022)
Table 55. Europe Recombinant Factor VIII Sales by Application (2017-2022) & (K Units)
Table 56. Europe Recombinant Factor VIII Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Recombinant Factor VIII Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Recombinant Factor VIII Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Recombinant Factor VIII Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Recombinant Factor VIII Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Recombinant Factor VIII Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Recombinant Factor VIII Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Recombinant Factor VIII Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Recombinant Factor VIII Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Recombinant Factor VIII
Table 66. Key Market Challenges & Risks of Recombinant Factor VIII
Table 67. Key Industry Trends of Recombinant Factor VIII
Table 68. Recombinant Factor VIII Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Recombinant Factor VIII Distributors List
Table 71. Recombinant Factor VIII Customer List
Table 72. Global Recombinant Factor VIII Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Recombinant Factor VIII Sales Market Forecast by Region
Table 74. Global Recombinant Factor VIII Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Recombinant Factor VIII Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Recombinant Factor VIII Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Recombinant Factor VIII Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Recombinant Factor VIII Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Recombinant Factor VIII Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Recombinant Factor VIII Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Recombinant Factor VIII Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Recombinant Factor VIII Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Recombinant Factor VIII Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Recombinant Factor VIII Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Recombinant Factor VIII Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Recombinant Factor VIII Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Recombinant Factor VIII Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Recombinant Factor VIII Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Recombinant Factor VIII Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Recombinant Factor VIII Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Recombinant Factor VIII Revenue Market Share Forecast by Application (2023-2028)
Table 92. Takeda Basic Information, Recombinant Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 93. Takeda Recombinant Factor VIII Product Offered
Table 94. Takeda Recombinant Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Takeda Main Business
Table 96. Takeda Latest Developments
Table 97. Bayer Basic Information, Recombinant Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 98. Bayer Recombinant Factor VIII Product Offered
Table 99. Bayer Recombinant Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Bayer Main Business
Table 101. Bayer Latest Developments
Table 102. CSL Basic Information, Recombinant Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 103. CSL Recombinant Factor VIII Product Offered
Table 104. CSL Recombinant Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. CSL Main Business
Table 106. CSL Latest Developments
Table 107. Pfizer Basic Information, Recombinant Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 108. Pfizer Recombinant Factor VIII Product Offered
Table 109. Pfizer Recombinant Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Pfizer Main Business
Table 111. Pfizer Latest Developments
Table 112. Biogen Basic Information, Recombinant Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 113. Biogen Recombinant Factor VIII Product Offered
Table 114. Biogen Recombinant Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Biogen Main Business
Table 116. Biogen Latest Developments
Table 117. Octapharma Basic Information, Recombinant Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 118. Octapharma Recombinant Factor VIII Product Offered
Table 119. Octapharma Recombinant Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Octapharma Main Business
Table 121. Octapharma Latest Developments
Table 122. NovoNordisk Basic Information, Recombinant Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 123. NovoNordisk Recombinant Factor VIII Product Offered
Table 124. NovoNordisk Recombinant Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. NovoNordisk Main Business
Table 126. NovoNordisk Latest Developments
List of Figures
Figure 1. Picture of Recombinant Factor VIII
Figure 2. Recombinant Factor VIII Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Factor VIII Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Recombinant Factor VIII Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Recombinant Factor VIII Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 200IU
Figure 10. Product Picture of 250IU
Figure 11. Global Recombinant Factor VIII Sales Market Share by Type in 2021
Figure 12. Global Recombinant Factor VIII Revenue Market Share by Type (2017-2022)
Figure 13. Recombinant Factor VIII Consumed in Hospital
Figure 14. Global Recombinant Factor VIII Market: Hospital (2017-2022) & (K Units)
Figure 15. Recombinant Factor VIII Consumed in Pharmacy
Figure 16. Global Recombinant Factor VIII Market: Pharmacy (2017-2022) & (K Units)
Figure 17. Global Recombinant Factor VIII Sales Market Share by Application (2017-2022)
Figure 18. Global Recombinant Factor VIII Revenue Market Share by Application in 2021
Figure 19. Recombinant Factor VIII Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Recombinant Factor VIII Revenue Market Share by Company in 2021
Figure 21. Global Recombinant Factor VIII Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Recombinant Factor VIII Revenue Market Share by Geographic Region in 2021
Figure 23. Global Recombinant Factor VIII Sales Market Share by Region (2017-2022)
Figure 24. Global Recombinant Factor VIII Revenue Market Share by Country/Region in 2021
Figure 25. Americas Recombinant Factor VIII Sales 2017-2022 (K Units)
Figure 26. Americas Recombinant Factor VIII Revenue 2017-2022 ($ Millions)
Figure 27. APAC Recombinant Factor VIII Sales 2017-2022 (K Units)
Figure 28. APAC Recombinant Factor VIII Revenue 2017-2022 ($ Millions)
Figure 29. Europe Recombinant Factor VIII Sales 2017-2022 (K Units)
Figure 30. Europe Recombinant Factor VIII Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Recombinant Factor VIII Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Recombinant Factor VIII Revenue 2017-2022 ($ Millions)
Figure 33. Americas Recombinant Factor VIII Sales Market Share by Country in 2021
Figure 34. Americas Recombinant Factor VIII Revenue Market Share by Country in 2021
Figure 35. United States Recombinant Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Recombinant Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Recombinant Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Recombinant Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Recombinant Factor VIII Sales Market Share by Region in 2021
Figure 40. APAC Recombinant Factor VIII Revenue Market Share by Regions in 2021
Figure 41. China Recombinant Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Recombinant Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Recombinant Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Recombinant Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Recombinant Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Recombinant Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Recombinant Factor VIII Sales Market Share by Country in 2021
Figure 48. Europe Recombinant Factor VIII Revenue Market Share by Country in 2021
Figure 49. Germany Recombinant Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Recombinant Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Recombinant Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Recombinant Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Recombinant Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Recombinant Factor VIII Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Recombinant Factor VIII Revenue Market Share by Country in 2021
Figure 56. Egypt Recombinant Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Recombinant Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Recombinant Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Recombinant Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Recombinant Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Recombinant Factor VIII in 2021
Figure 62. Manufacturing Process Analysis of Recombinant Factor VIII
Figure 63. Industry Chain Structure of Recombinant Factor VIII
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
